Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Bptrack-Trio 6.25 Tablet

Prescription Icon
Prescription Required

Marketer

Saiboon Lifecare Pvt Ltd

Salt Composition

Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)

Overview Bptrack-Trio 6.25 Tablet

Hypernia-Trio 6.25mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of stroke and heart attack. Administer Hypernia-Trio 6.25mg with food, at a consistent daily time, following your doctor's prescribed dosage. Continuous use is crucial, as directed by your physician. The medication includes a diuretic, increasing urination; therefore, avoid taking it within four hours of bedtime. Consistent use maximizes therapeutic benefits, even in the absence of symptoms, since hypertension is often asymptomatic. Discontinuing treatment elevates stroke and heart attack risk. Common side effects include ankle edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential muscle weakness, xerostomia, and polydipsia. Prior to use, inform your doctor of any renal or hepatic dysfunction, pregnancy, breastfeeding, or concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is essential to ensure treatment efficacy.

Primary Ingredients of Bptrack-Trio 6.25 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Bptrack-Trio 6.25 Tablet

Elevated blood pressure

Major Benefits of Bptrack-Trio 6.25 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Bptrack-Trio 6.25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Bptrack-Trio 6.25 Tablet:

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations
  • Sleepiness
  • Increased blood uric acid
  • Glucose intolerance
  • Taste change
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Upset stomach
  • Altered blood lipid level

How to use Bptrack-Trio 6.25 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Bptrack-Trio 6.25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Bptrack-Trio 6.25 Tablet works:

Bptrack-Trio 6.25mg tablets contain telmisartan, cilnidipine, and chlorthalidone, a three-drug formulation. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both act to dilate blood vessels, thus reducing blood pressure. Chlorthalidone, a thiazide diuretic, lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to vasodilation and improved circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Bptrack-Trio 6.25 Tablet is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Bptrack-Trio 6.25 Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Bptrack-Trio 6.25 Tablet use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Bptrack-Trio 6.25 Tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Bptrack-Trio 6.25 mg tablets, potentially requiring dosage modification. Medical advice is necessary. This medication is not advised for such individuals.

LiverLiverCAUTION

Patients with liver impairment should use Bptrack-Trio 6.25mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Bptrack-Trio 6.25mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Bptrack-Trio 6.25 Tablet :

Should you forget a dose of Bptrack-Trio 6.25 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bptrack-Trio 6.25 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart
Bptrack-Trio 6.25 Tablet
112
MRP 130
13% off